Jill Scott
About Jill Scott
Jill Scott is the Senior Counsel for Business Development and Alliance Management at Bristol Myers Squibb, with a background in legal roles at Zymeworks Inc., Allen Institute, and Center for Infectious Disease Research.
Current Role
Jill Scott serves as the Senior Counsel, Business Development and Alliance Management at Bristol Myers Squibb. In her role, she leads as the counsel for approximately 30 of the company's global alliances across various sectors including non-profit, biotech, and pharma collaborators. She provides practical, risk-based legal advice on data transfer, intellectual property, clinical development, and commercial law. Additionally, she drafts and negotiates complex licensing and collaboration agreements and supports equity investments and multi-billion dollar M&A transactions.
Previous Positions
Before joining Bristol Myers Squibb, Jill Scott held several significant roles. At Zymeworks Inc., she worked as Senior Director, Legal for four months in 2022 and was the Director, Legal from 2019 to 2022. Prior to Zymeworks Inc., she was the Associate General Counsel at the Allen Institute from 2014 to 2019 and at the Center for Infectious Disease Research from 2010 to 2014. Early in her career, she was an Associate Attorney at Bennett Bigelow & Leedom, P.S. and a Legal Intern in the International Health Regulations at the World Health Organization.
Educational Background
Jill Scott obtained her Juris Doctor with High Honors from the University of Washington School of Law, graduating in the top 5% of her class. She also earned a Master in Public Health with a focus on Public Health Genetics from the University of Washington School of Public Health. Her undergraduate education includes a B.S. in Microbiology and a B.A. in International Studies from Oregon State University, where she also minored in Spanish and Chemistry. Additionally, she studied Spanish and Ecuadorian Studies at Escuela Politécnica Javeriana del Ecuador.
Professional Contributions
Jill Scott is actively involved in professional service as the Co-Chair of the BMS Law Department Pro Bono Committee. In her professional capacity, she focuses on providing risk-based legal strategies and navigates issues within data transfer, intellectual property, clinical development, and commercial law. Her role encompasses drafting and negotiating strategic licensing and collaboration agreements across various stages of research, clinical, and commercial development, including digital health tools and diagnostics.